Patent · US Active

Compounds

US8575162B2 · kind B2 · utility

4Cited by
5References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2010
Grant dateNov 5, 2013
Priority date
Expiry dateNov 7, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I):and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.